The Asia Pacific dialysis access treatment device market will grow modestly through 2029, driven by rising incidence of ESRD due to the aging population, coupled with government initiatives to improve access to dialysis care. However, market growth will be hindered to some extent due to the COVID-19 pandemic.
This Medtech 360 Report provides high-level market metrics for dialysis access treatment devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.
- Dialysis Access Treatment Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Bishwjit Ghoshal, MBA; Sai Harshita Yangam
Bishwjit Ghoshal is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.
Follow Bishwjit on twitter: @Bishwjit_DRG